Prolyl endopeptidase inhibitors from the roots of Lindera strychnifolia F.!Vill

被引:32
作者
Kobayashi, W [1 ]
Miyase, T [1 ]
Sano, M [1 ]
Umehara, K [1 ]
Warashina, T [1 ]
Noguchi, H [1 ]
机构
[1] Univ Shizuoka, Sch Pharmaceut Sci, Inst Environm Sci, Shizuoka 4228526, Japan
关键词
isolinderalactone; prolyl endopeptidase (PEP) inhibitor; Lindera strychnifolia; sesquiterpene; rat brain supernatant;
D O I
10.1248/bpb.25.1049
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Prolyl endopeptidase (PEP, EC 3.4.21.26) has been proposed to play a role in degradation of proline-containing neuropeptides involved in the processes of learning and memory, e.g., vasopressin, substance P, and thyrotropin-releasing hormone (TRH). In the course of our search for bioactive constituents in medicinal plants, we studied the PEP inhibitory constituents of the roots of Lindera strychnifolia F. VILL and isolated two known tannins, epicatechin (1) and aesculitannin B (2), and four known sesquiterpenes, linderene (3), linderene acetate (4), linderalactone (5) and isolinderalactone (6) as inhibitors. On the inhibitory activities of six compounds against PEP from Flavobacterium meningosepticum and that from rat brain supernatant, compounds 1, 2 and 4 inhibited the enzyme from Flavobacterium more strongly than that from rat brain supernatant. However, compounds 3, 5 and 6 inhibited the enzymes from both origins to the same extent and furthermore, compound 6 was the strongest natural inhibitor against PEP from rat brain supernatant. The kinetic study of these inhibitors indicated that compounds 1, 2 are noncompetitive inhibitors and compounds 3-6 are competitive inhibitors. This is the first example of non-phenolic constituents showing significant competitive inhibitory activity being isolated from natural medicines.
引用
收藏
页码:1049 / 1052
页数:4
相关论文
共 24 条
[1]
DEFICIENCY OF KALLIKREIN-LIKE ENZYME-ACTIVITIES IN CEREBRAL TISSUE OF PATIENTS WITH ALZHEIMERS-DISEASE [J].
AOYAGI, T ;
WADA, T ;
NAGAI, M ;
KOJIMA, F ;
HARADA, S ;
TAKEUCHI, T ;
TAKAHASHI, H ;
HIROKAWA, K ;
TSUMITA, T .
EXPERIENTIA, 1990, 46 (01) :94-97
[2]
A MAJOR METABOLITE OF ARGININE VASOPRESSIN IN THE BRAIN IS A HIGHLY POTENT NEUROPEPTIDE [J].
BURBACH, JPH ;
KOVACS, GL ;
DEWIED, D ;
VANNISPEN, JW ;
GREVEN, HM .
SCIENCE, 1983, 221 (4617) :1310-1312
[3]
Proline specific peptidases [J].
Cunningham, DF ;
O'Connor, B .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1997, 1343 (02) :160-186
[4]
CENTRAL TARGET FOR THE BEHAVIORAL-EFFECTS OF VASOPRESSIN NEUROPEPTIDES [J].
DEWIED, D ;
GAFFORI, O ;
VANREE, JM ;
DEJONG, W .
NATURE, 1984, 308 (5956) :276-278
[5]
Fan W, 2000, CHEM PHARM BULL, V48, P1055
[6]
Fan WZ, 1999, BIOL PHARM BULL, V22, P157, DOI 10.1248/bpb.22.157
[7]
Prolyl endopeptidase inhibitors from the underground part of Rhodiola sachalinensis [J].
Fan, WZ ;
Tezuka, Y ;
Ni, KM ;
Kadota, S .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2001, 49 (04) :396-401
[8]
COLOCALIZATION OF PROLYL ENDOPEPTIDASE AND AMYLOID BETA-PEPTIDE IN BRAINS OF SENESCENCE-ACCELERATED MOUSE [J].
FUKUNARI, A ;
KATO, A ;
SAKAI, Y ;
YOSHIMOTO, T ;
ISHIURA, S ;
SUZUKI, K ;
NAKAJIMA, T .
NEUROSCIENCE LETTERS, 1994, 176 (02) :201-204
[9]
HASHIMOTO G, 1996, ILLUSTRATED CYCLOPED, P164
[10]
ICHAI C, 1994, J NEUROCHEM, V62, P645